Selective use of vandetanib in the treatment of thyroid cancer
Poupak Fallahi,1 Flavia Di Bari,2 Silvia Martina Ferrari,1 Roberto Spisni,3 Gabriele Materazzi,3 Paolo Miccoli,3 Salvatore Benvenga,2 Alessandro Antonelli1 1Department of Clinical and Experimental Medicine, University of Pisa, Pisa, 2Department of Clinical and Experimental Medicine, Section...
Saved in:
Main Authors: | Fallahi P (Author), Di Bari F (Author), Ferrari SM (Author), Spisni R (Author), Materazzi G (Author), Miccoli P (Author), Benvenga S (Author), Antonelli A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phototoxic drug eruption induced by vandetanib used for the treatment of metastatic medullary thyroid cancer
by: Ecem Bostan, et al.
Published: (2022) -
Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism
by: Silvia Martina Ferrari, et al.
Published: (2021) -
Dermoscopic findings of perifollicular pigmentation associated with vandetanib
by: Jade Cury-Martins, et al.
Published: (2018) -
Vandetanib induced phototoxic reaction progressed to toxic epidermal necrolysis
by: Busra Demirbag Gul, et al.
Published: (2022) -
Clinical utility of exemestane in the treatment of breast cancer
by: Zucchini G, et al.
Published: (2015)